Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole A Federico

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Annual Review of Biomedical Data Science|April 10, 2024
Biomedical Data Science, Artificial Intelligence, and Ethics: Navigating Challenges in the Face of Explosive GrowthCarole A Federico, Artem A Trotsyuk
BMJ (Clinical Research Ed.)|March 22, 2018
Trials that say "maybe": the disconnect between exploratory and confirmatory testing after drug approvalBenjamin Carlisle, Carole A Federico, Jonathan Kimmelman
The American Journal of Bioethics : AJOB|October 9, 2023
Unreliable LLM Bioethics Assistants: Ethical and Pedagogical RisksLea Goetz, Markus Trengove, Artem Trotsyuk, et al.
Pain|September 21, 2020
Response to Moisset et alCarole A Federico, Jeffrey S Mogil, Tim Ramsay, et al.
Frontiers in Human Neuroscience|October 19, 2010
Reducing barriers to ethics in neuroscienceJudy Illes, Kate Tairyan, Carole A Federico, et al.
Pain|January 25, 2020
A systematic review and meta-analysis of pregabalin preclinical studiesCarole A Federico, Jeffrey S Mogil, Tim Ramsay, et al.
BMC Medical Ethics|June 4, 2011
Untapped ethical resources for neurodegeneration researchJulie M Robillard, Carole A Federico, Kate Tairyan, et al.
Bioinspiration & Biomimetics|March 14, 2025
Ethics of biohybrid robotics and invertebrate research: biohybrid robotic jellyfish as a case studyNicole W Xu, Olga Lenczewska, Sarah E Wieten, et al.
Science Translational Medicine|September 13, 2023
Stronger regulation of AI in biomedicineArtem A Trotsyuk, Carole A Federico, Mildred K Cho, et al.
JAMA Internal Medicine|November 27, 2018
Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications: A Systematic ReviewCarole A Federico, Taiji Wang, Adélaïde Doussau, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Annual Review of Biomedical Data Science|April 10, 2024
Biomedical Data Science, Artificial Intelligence, and Ethics: Navigating Challenges in the Face of Explosive GrowthCarole A Federico, Artem A Trotsyuk
BMJ (Clinical Research Ed.)|March 22, 2018
Trials that say "maybe": the disconnect between exploratory and confirmatory testing after drug approvalBenjamin Carlisle, Carole A Federico, Jonathan Kimmelman
The American Journal of Bioethics : AJOB|October 9, 2023
Unreliable LLM Bioethics Assistants: Ethical and Pedagogical RisksLea Goetz, Markus Trengove, Artem Trotsyuk, et al.
Pain|September 21, 2020
Response to Moisset et alCarole A Federico, Jeffrey S Mogil, Tim Ramsay, et al.
Frontiers in Human Neuroscience|October 19, 2010
Reducing barriers to ethics in neuroscienceJudy Illes, Kate Tairyan, Carole A Federico, et al.
Pain|January 25, 2020
A systematic review and meta-analysis of pregabalin preclinical studiesCarole A Federico, Jeffrey S Mogil, Tim Ramsay, et al.
BMC Medical Ethics|June 4, 2011
Untapped ethical resources for neurodegeneration researchJulie M Robillard, Carole A Federico, Kate Tairyan, et al.
Bioinspiration & Biomimetics|March 14, 2025
Ethics of biohybrid robotics and invertebrate research: biohybrid robotic jellyfish as a case studyNicole W Xu, Olga Lenczewska, Sarah E Wieten, et al.
Science Translational Medicine|September 13, 2023
Stronger regulation of AI in biomedicineArtem A Trotsyuk, Carole A Federico, Mildred K Cho, et al.
JAMA Internal Medicine|November 27, 2018
Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications: A Systematic ReviewCarole A Federico, Taiji Wang, Adélaïde Doussau, et al.
Pageof 2